Dr. Denise Park (center) and members of her lab discuss recent findings published in Neurology. Park and her colleagues found that an early relationship between amyloid, the protein buildup in the brain commonly associated with Alzheimer’s, and memory was present in adults ages 30 to 59. Credit: University of Texas at Dallas New research from The […]Continue Reading ...
Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer’s disease. AD is characterized by the accumulation of beta-amyloid plaques, tau fibers and the loss of neurons in the brain. Currently, no FDA-approved drugs […]Continue Reading ...
More than 30 years have passed since the amyloid precursor protein was first identified. In the late 1980s, several research teams across the globe traced the protein fragment found in amyloid plaques back to a gene located on chromosome 21. The gene encodes a longer protein that is cleaved into several fragments, one of which […]Continue Reading ...
Credit: CC0 Public Domain A hypothesis which has been the standard way of explaining how the body develops Alzheimer’s Disease for almost 30 years is flawed, according to a University of Manchester biologist. The amyloid cascade hypothesis argues that a series of stages, starting from the deposition of a starch-like protein called amyloid and ending […]Continue Reading ...
PET scan of a human brain with Alzheimer’s disease. Credit: public domain Researchers at King’s College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer’s disease which may explain why so many drug trials have failed. The study also identifies a clinically approved drug which breaks the vicious cycle and protects against […]Continue Reading ...
In a report in The American Journal of Pathology investigators describe the generation of a successful novel transgenic rat model that accumulates amyloid specifically in brain blood vessels and strongly mimics many of the associated detrimental changes that are observed in humans – a condition known as cerebral amyloid angiopathy (CAA), which is also commonly […]Continue Reading ...
The century old mission to understand how the proteins responsible for amyloid-based diseases such as Alzheimer’s, Huntingdon’s and Parkinson’s work has taken major steps forward in the last 12 months, thanks to a revolution in a powerful microscopy technique used by scientists. High-powered microscopes using electrons instead of light to ‘see’ the actual shape of […]Continue Reading ...
Compared to a control (left), a soluble version of TLR5 (right) reduces the formation of amyloid plaques (brown) in the brains of mice that produce large amounts of human β-amyloid. Credit: Chakrabarty et al., 2018 Researchers at the University of Florida have discovered that a modified version of an important immune cell protein could be […]Continue Reading ...
An interview with Dr. Lloyd Tran from NeuroActiva, discussing the major barriers to Alzheimer’s research and development over the past 40 years, and how the IUFAA are working to overcome these challenges. Why have so many Alzheimer’s drugs failed in the past 40 years? It has now been 112 years since Dr. Alois Alzheimer first […]Continue Reading ...
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer’s disease, and are able to seed amyloid pathology in mice. The research, published in Nature, follows on from the team’s 2015 study that found evidence of amyloid pathology in people who […]Continue Reading ...
Researchers at the University of Texas have developed a new vaccine that reduces the build-up of the toxic proteins associated with Alzheimer’s disease and proven its efficacy in an animal model. The research may pave the way for a clinical trial. Toxic amyloid plaques (red) and tau tangles (brown) form on the brain of a […]Continue Reading ...
Brain scans are one method used to measure the amount of amyloid in the brain, which may be a sign of mild cognitive impairment. Credit: The University of Miami Miller School of Medicine Finding an effective way to identify people with mild cognitive impairment who are most likely to go on to develop Alzheimer’s disease […]Continue Reading ...
Scientists at the University of Leeds have used cryo-electron microscopes to reveal the structure of amyloid – the abnormal protein that accumulates in the body and causes diseases such as Alzheimer’s, Parkinson’s, and Huntington’s. Credit: University of Leeds The high-powered, “game-changing” microscopes use electrons rather than light to visualize the shape of samples at near-atomic […]Continue Reading ...
Oct 12 2018 Scientists at the University of Waterloo have discovered that antidepressant medications can be used to treat Alzheimer’s disease. The study, recently published in ACS Chemical Neuroscience, found that selective serotonin uptake inhibitors (SSRI medication) can delay the development and growth of amyloid-beta proteins, which can clump together and form a plaque, contributing […]Continue Reading ...
- Piece of puzzle unlocked in what drives alcohol addiction
- Researchers investigate whether Zika reservoirs are found in the Americas
- Compounds found in coffee may inhibit growth of prostate cancer
- Lab Innovations returns to the NEC on 30 & 31 October 2019
- How genes affect tobacco and alcohol use
- Plant cellulose bone implants are “viable” option to support new bone growth, study finds
- Older people living in retirement communities benefit from improved health
- UTSA professor helps train first responders to detect prescription opioid overdoses
- Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
- Smoking may limit body’s ability to fight dangerous form of skin cancer
- Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
- TGen and ABL sign agreement to distribute new TB test technology
- UCD researchers lead development of new urine test to detect prostate cancer
- Miniature brains that can move muscles, grown in the lab
- Servier and Oncodesign announce research and drug development partnership
- FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
- TB Medicine Pretomanid Enters Regulatory Review Process in the United States
- Breastfeeding can erase effects of prenatal violence for newborns
- Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
- Space worries – shingles affecting astronauts says NASA